selected scholarly activity
-
conferences
- Do instructions for at-home dried blood spot (DBS) collection affect the quality of collection? Data from the Canadian Longitudinal Study on Aging (CLSA) COVID-19 seroprevalence study. Clinical Biochemistry. 115-115. 2022
- Monitoring and adjusting for analytical bias in chemistry tests using longitudinal quality control (LQC) samples. Clinical Biochemistry. 120-120. 2022
- Method development and validation of tranexamic acid by LC-MS/MS. Clinical Biochemistry. 90-90. 2019
- Validation and evaluation of infliximab assay in IBD. Clinical Biochemistry. 94-94. 2019
- A pathway to limit AST testing. Clinical Biochemistry. 57-58. 2018
- CSCC harmonized reference intervals working group: Progress towards harmonization. Clinical Biochemistry. 69-70. 2018
- Development of Canadian reference intervals and confidence intervals using data mining: Application of the Arzideh statistical method. Clinical Biochemistry. 61-62. 2018
- Lipid reporting across Canada: current variability and proposed harmonized lipid profile and interpretive comments. Clinical Biochemistry. 61-61. 2018
- Reference interval studies for chemistry analytes: judgement of risk of bias and applicability. Clinical Biochemistry. 68-69. 2018
-
journal articles
- Development of a second-tier method for C4, C5 and C2 acylcarnitine analysis in plasma. Clinical Biochemistry. 123:110698-110698. 2024
- Alerting to acute kidney injury - Challenges, benefits, and strategies. Practical Laboratory Medicine. 30:e00270-e00270. 2022
- Analysis of serum tranexamic acid in patients undergoing open heart surgery. Clinical Biochemistry. 87:74-78. 2021
- The potential of reducing AST testing in hospital settings. Clinical Biochemistry. 64:57-59. 2019
- The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations. Clinical Biochemistry. 58:53-59. 2018